Wegovy and Zepbound Boost Obesity

Wegovy and Zepbound Boost Obesity

The New York Times

It’s a problem that doctors call nonadherence — the common human tendency to resist medical treatment — and it leads to billions of dollars of preventable medical costs each year. But that resistance may be overcome by the blockbuster obesity drugs Wegovy and Zepbound, which have astounded the world with the way they help people lose weight and keep it off.

#HEALTH #English #CN
Read more at The New York Times